MRC1 and cancer: Among hypermutated cancers presenting ≥10 Mut/Mb, ∼25% are associated with mutations in MMR genes alone, whereas a large number of ultra-hypermutated cancers (≥100 Mut/Mb) show mutations affecting both MMR and the replicative DNA polymerases, mainly POLE (Jansen et al, 2016).